Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Invest Ophthalmol Vis Sci 55(12):81739 Thaller M et al (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes
Dan McKees fiscal 2027 budget proposal, which seeks to eliminate Medicaid coverage for GLP-1 obesity treatments
If your insurance company denies coverage for GLP-1 medications, you have the right to appeal the decision
Brand-name Zepbound or Mounjaro can run over $1,000 per month without insurance
US$ 24.85
US$ 25.09
US$ 23.92
US$ 21.96
US$ 25.88
